News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
269,345 Results
Type
Article (14327)
Company Profile (281)
Press Release (254737)
Multimedia
Podcasts (49)
Webinars (7)
Section
Business (79644)
Career Advice (153)
Deals (13252)
Drug Delivery (35)
Drug Development (50546)
Employer Resources (31)
FDA (5743)
Job Trends (5147)
News (144707)
Policy (10113)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21711)
ALS (69)
Alzheimer's disease (853)
Antibody-drug conjugate (ADC) (108)
Approvals (5770)
Artificial intelligence (134)
Autoimmune disease (19)
Automation (5)
Bankruptcy (105)
Best Places to Work (4565)
BIOSECURE Act (6)
Biosimilars (47)
Biotechnology (232)
Bladder cancer (59)
Brain cancer (20)
Breast cancer (161)
Cancer (1525)
Cardiovascular disease (121)
Career advice (134)
Career pathing (2)
CAR-T (124)
Cell therapy (343)
Cervical cancer (9)
Clinical research (41251)
Collaboration (563)
Compensation (281)
Complete response letters (13)
COVID-19 (1036)
CRISPR (44)
C-suite (172)
Cystic fibrosis (78)
Data (1619)
Denatured (11)
Depression (32)
Diabetes (143)
Diagnostics (1303)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (86)
Drug pricing (29)
Drug shortages (3)
Duchenne muscular dystrophy (92)
Earnings (30172)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (48832)
Executive appointments (477)
FDA (6521)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (518)
Gene editing (102)
Generative AI (10)
Gene therapy (266)
GLP-1 (372)
Government (1107)
Grass and pollen (2)
Guidances (71)
Healthcare (6601)
Huntington's disease (23)
IgA nephropathy (26)
Immunology and inflammation (100)
Indications (20)
Infectious disease (1103)
Inflammatory bowel disease (119)
Inflation Reduction Act (8)
Influenza (20)
Intellectual property (68)
Interviews (18)
IPO (7291)
IRA (11)
Job creations (865)
Job search strategy (127)
Kidney cancer (7)
Labor market (8)
Layoffs (216)
Leadership (3)
Legal (1397)
Liver cancer (34)
Lung cancer (207)
Lymphoma (103)
Machine learning (5)
Management (7)
Manufacturing (148)
MASH (63)
Medical device (2605)
Medtech (2606)
Mergers & acquisitions (6304)
Metabolic disorders (408)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1281)
NextGen: Class of 2025 (2018)
Non-profit (854)
Now hiring (22)
Obesity (197)
Opinion (103)
Ovarian cancer (67)
Pain (45)
Pancreatic cancer (60)
Parkinson's disease (124)
Partnered (8)
Patents (138)
Patient recruitment (83)
Peanut (35)
People (25715)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14556)
Phase II (19183)
Phase III (12137)
Pipeline (949)
Policy (49)
Postmarket research (861)
Preclinical (6164)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (299)
Real estate (1424)
Recruiting (12)
Regulatory (8728)
Reports (17)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (5)
RNA editing (5)
RSV (10)
Schizophrenia (64)
Series A (100)
Series B (70)
Service/supplier (1)
Sickle cell disease (41)
Special edition (12)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1978)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (12)
The Weekly (37)
Vaccines (218)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (73)
Last 7 days (634)
Last 30 days (1905)
Last 365 days (19348)
2025 (7137)
2024 (20572)
2023 (22430)
2022 (26853)
2021 (27844)
2020 (23389)
2019 (16266)
2018 (11762)
2017 (13759)
2016 (11855)
2015 (14366)
2014 (10405)
2013 (7498)
2012 (7558)
2011 (7631)
2010 (7442)
Location
Africa (148)
Alabama (43)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17368)
Australia (2963)
California (4085)
Canada (1181)
China (378)
Colorado (153)
Connecticut (156)
Delaware (110)
Europe (37422)
Florida (499)
Georgia (124)
Idaho (16)
Illinois (243)
India (10)
Indiana (94)
Iowa (2)
Japan (80)
Kansas (63)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (494)
Massachusetts (3256)
Michigan (74)
Minnesota (154)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (1014)
New Mexico (12)
New York (1093)
North Carolina (574)
North Dakota (5)
Northern California (1827)
Ohio (115)
Oklahoma (9)
Oregon (21)
Pennsylvania (773)
Puerto Rico (6)
Rhode Island (19)
South America (209)
South Carolina (5)
Southern California (1564)
Tennessee (25)
Texas (475)
United States (13956)
Utah (56)
Virginia (84)
Washington D.C. (31)
Washington State (362)
Wisconsin (17)
269,345 Results for "rani therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
March 26, 2025
·
1 min read
Press Releases
Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update
April 1, 2025
·
12 min read
Business
Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”)(Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a definitive agreement with ProGen Co., Ltd.
June 24, 2024
·
7 min read
Business
Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter ended March 31, 2024 and provided a corporate update.
May 6, 2024
·
7 min read
Press Releases
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
February 5, 2025
·
7 min read
Biotech Bay
Rani Therapeutics to Participate in May 2024 Investor Conferences
Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, announced that the Company will participate in two upcoming investor conferences in May 2024.
May 14, 2024
·
1 min read
Press Releases
Rani Therapeutics to Participate in Upcoming Investor Conferences
November 8, 2024
·
1 min read
Press Releases
Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102
March 26, 2025
·
8 min read
Business
Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update
Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today reported financial results for the quarter and full year ended December 31, 2023 and provided a corporate update.
March 20, 2024
·
11 min read
Press Releases
Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update
November 14, 2024
·
8 min read
1 of 26,935
Next
